Dow Up 1.30% Nasdaq Up 0.37%

Navidea Biopharmaceuticals, Inc (NAVB)

-NYSE MKT
1.36 Down 0.02(1.45%) 4:05PM EDT
Prev Close:1.38
Open:1.39
Bid:1.34 x 1600
Ask:1.57 x 5400
1y Target Est:4.05
Beta:1.1
Next Earnings Date:N/A
Day's Range:1.35 - 1.39
52wk Range:1.11 - 2.25
Volume:575,985
Avg Vol (3m):603,432
Market Cap:204.22M
P/E (ttm):N/A
EPS (ttm):-0.34
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for NAVB

Comparison

Symbol% ChgMkt Cap
NAVBDown 1.45%204.22M
LLYUp 2.00%71.77B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):75.03
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.26
Quarterly EPS Est (Sep-14) :-0.06
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision diagnostics and radiopharmaceutical agents. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback